State-of-the-art diagnostics in the fight against lifestyle diseases
Thanks to the use of the innovative mMR scanner from Siemens, we can offer you examinations that are unique on a national scale. PET/MR is a diagnostic examination during which magnetic resonance imaging (MRI) and positron emission tomography (PET) of the whole body (from the top of the head to the middle of the thighs) are performed simultaneously.
The PET MR method uses fully diagnostic magnetic resonance, in the case of our scanner with an induction power of up to 3T. This allows for an accurate anatomical image of tissues and organs.
As a result, the PET/MR method provides information on the structure, function and metabolism of organs and systems in the patient’s body. Positron emission tomography with magnetic resonance imaging is extremely useful in the process of early detection and treatment of many diseases and provides a number of benefits for our patients. Comparison of the PET/MR technique to the classic PET/CT examinations can be found in the Comparison of PET examinations tab.
We are proud of our reputation as a leader in PET/CT and PET/MR. Our team of highly qualified doctors and medical technologists work with passion and commitment to provide our patients with the best possible care.
Benefits for the patient
Early detection of lesions throughout the body
Due to the civilization changes that are taking place in the modern world, the number of people diagnosed with cancer, neurological and many other serious diseases is growing exponentially. The use of a modern PET/MR examination in diagnosis is:
- early detection of a possible disease, and therefore a significant increase in the chances of successful treatment,
- reduction of radiation dose compared to PET/CT examinations,
- few contraindications to perform the examination.
Accurate determination of the location and severity of diseases throughout the body
People who have been diagnosed with cancer, neurological disease or suffering from chronic inflammatory conditions of unknown cause very often need a very quick and accurate diagnosis. Using our equipment to perform diagnostic examinations of positron emission tomography with magnetic resonance (PET/MR), our patients receive:
- examination of the whole body and precise differentiation of lesions, which allows to determine the degree of local advancement and distant changes (staging),
- two examinations in one – the patient receives a fully diagnostic magnetic resonance imaging at the same time, which means that there is no need to perform additional examinations, and the treatment process can begin faster,
- examination and description performed by two specialist doctors within 10 days from the moment of making the decision to perform the examination.
Evaluation of the effectiveness of cancer treatment and early detection of possible recurrence of the disease
Our highly specialized PET/MR examination is extremely helpful for people who have had cancer. Due to the accuracy of the examination, which detects even small lesions, and the fact that the examination involves a scan of the whole body, we can:
- evaluate the effectiveness of response to surgical and/or oncological treatment,
- detecting the area of recurrence and possible distant metastases at a very early stage,
- reduce the radiation dose compared to PET/CT.
Preparation for PET/MR examination
When registering for a examination, you have to:
- provide the clinical diagnosis and the purpose of the examination,
- inform about the presence of possible contraindications to the examination,
- inform about comorbidities, including diabetes, and about medications taken,
- provide the date of surgery performed within the last 6 months and the date of completion of chemotherapy and radiotherapy.
Before the examination, the patient should be on an empty stomach (at least 6 hours). An elevated blood glucose level (above 140 mg%) is a contraindication to the examination, because the images obtained then are non-diagnostic and of poor quality due to the high background of the surrounding tissues.
24 hours before the examination, an isocaloric and low-carbohydrate diet should be used, excluding foods such as: potatoes, pasta, rice, cereals, bread, cookies, sweets, carbonated and alcoholic drinks. You can eat meat, hard cheese, eggs, tofu, butter, vegetables without starch.
Also, 24 hours before the examination, you should avoid intense physical effort and deep massages, and you should not smoke tobacco products.
Before the examination, the patient should be well hydrated. It is recommended to drink plenty of still water (not flavored, no additives, no sugar), because the tracer is excreted mainly through the urinary system. Thus, exposure to ionizing radiation is reduced and excretion of the radiotracer is increased.
Diabetic patients require special preparation for PET with FDG. Therefore, when registering for the study, it is absolutely necessary to inform about the treatment for diabetes and the medications taken. If you are taking metformin-based medications, stop taking them 3 days before the scheduled PET scan. People taking short-acting or long-acting insulin should contact our medical staff to determine the dosage before and on the day of the PET scan.
The course of the PET/MR examination
When applying for the examination, you must have:
- identity card or other identity document,
- results of previous examinations (also CDs) and Information Cards from hospital stays,
- complete documentation in the case of surgery (neurosurgery, vascular) or implantation of a valve, implant,
- orthopedic prosthesis, vascular clips (provide a detailed description and the type of material from which the implanted element was made),
- current blood test result for serum creatinine (not older than 14 days),
- be dressed in/or have with you clothes without metal elements (zippers, rivets, buckles).
After arriving at our lab an completing the necessary documentation, the patient will be examined by a doctor. Then a venflon is inserted and a radiopharmaceutical is administered intravenously. The activity of the radiopharmaceutical is selected individually for each patient, based on body weight, to minimize exposure to ionizing radiation.
For the next hour, the patient waits for examination in a separate room, and 60 minutes is needed for the uptake of the tracer by the cells. After an hour, the patient will be asked for an examination, during which you should lie still, be very calm, so that the images are not blurred. The examination lasts from 40 to 70 minutes.
After the examination is completed, the intravenous line is removed and the patient can return home and return to their daily activities. Remember to drink water to help flush out the radioactive substance. In addition, it is recommended to avoid contact with pregnant women and people under 16 years for a day.
Step by step
5 steps to get your PET/MR result
Make an appointment for a free qualifying visit:
phone: 85 500 10 25,
in person: Żurawia 71a, Bialystok.
Step 2Free qualification for the examination
Qualification for your convenience can be done by phone, and our specialists will contact you at the agreed time. You will always be asked to provide the necessary medical documentation.
Step 3Arranging the date of the examination
Patients who are qualified by the doctor for the examination set its date together with the registration. You will be asked to make an advance payment for the purchase of the radiopharmaceutical that will be imported for you.
Step 4Performing the examination
Patients are scheduled for a specific hour and do not need to wait for the examination longer than necessary. Before administering the radiopharmaceutical, the patient is examined by a doctor.
Step 5Collect examination results
The examination result described by two specialist doctors is available after a few days. The whole period from the moment of the patient’s decision to receiving the examination results does not exceed 10 days.
Application of PET/MR examinations
- detection, assessment of malignancy, stage of advancement (local and distant metastases), assessment of response to treatment and diagnostics in the case of suspected tumor recurrence based on their metabolic activity and image in magnetic resonance imaging,
- assessment of the activity of neoplastic lesions in order to plan radiotherapy,
- assessment of tumor activity to indicate the place for biopsy,
- assessment of response to chemo-, radio- and immunotherapy in oncological patients,
- detection, staging and assessment of brain tumor recurrence – significantly higher diagnostic sensitivity than PET-CT,
- imaging of head and neck tumors, e.g. cancer of the tongue, oral cavity, larynx – higher spatial resolution in relation to the PET / CT technique
- diagnostics of lung diseases, including: lung tumors, lung metastases – sensitivity comparable to PET-CT,
- diagnosis and assessment of mediastinal tumors,
- detection and assessment of the stage of pleural mesothelioma,
- assessment of the malignancy and advancement of breast tumors, including lymph nodes and distant metastases,
- assessment of the location of active inflammatory lesions in the course of inflammatory diseases (inflammatory bowel disease, sarcoidosis, vasculitis and others),
- diagnosis of focal changes in the liver,
- diagnosis of focal lesions in the skeletal system,
- exclusion/confirmation of the metastatic nature of the lesions, searching for the primary focus,
- assessment of the advancement and response to treatment of malignant tumors of the skeletal system,
- abdominal cancers, differential diagnosis, assessment of the advancement of lesions, suspicion of recurrence,
- hepatocellular carcinoma, gallbladder cancer, cholangiocarcinoma, kidney cancer – assessment of the degree of malignancy, advancement stage, suspicion of recurrence, assessment of response to treatment,
- pancreatic tumors, assessment of the nature of the changes and stage of advancement,
- gastrointestinal cancers (stomach, small intestine, large intestine, including rectum) – assessment of the degree of malignancy, advancement stage, response to treatment and suspicion of recurrence,
- prostate cancer, assessment of the primary lesion, search for recurrence foci and assessment of the advancement of changes,
- diagnostics, staging and recurrence of gynecological cancers in women in the pelvic area: ovarian cancer, endometrial cancer, cervical cancer,
- cancers of the musculoskeletal system: assessment of the stage of the disease, diagnosis of metastases/recurrences, assessment of response to treatment,
- malignant melanoma – the examination enables the detection of metastases (usually subcutaneous, to the bones, liver and brain) and evaluation of the effectiveness of treatment,
- lymphomas and other haematological diseases – assessment of the stage of the disease, recurrence, selection of the appropriate method of treatment and assessment of response to treatment,
- searching for the primary tumor focus,
- searching for foci of inflammation, fever of unknown etiology,
- location of parathyroid adenoma,
- suspected thyroid cancer recurrence, with a negative I-131 scintigraphy examination,
- diagnosis of neurodegenerative diseases, dementia – e.g. Alzheimer’s disease, differential diagnosis of fronto-temporal dementia (FTD) and Alzheimer’s disease (AD),
- location of epilepsy foci,
- assessment of myocardial viability.
We do not perform examinations in pregnant women and in people who have implanted cochlear implants, metallic elements that cannot be imaged in magnetic resonance, or there is no appropriate documentation to assess the patient’s safety.
PET/MR examination may be performed under specific conditions (always to the decision of the doctor supervising the examination, based on medical documentation):
- stents, vascular clips, stent grafts, cardioverter/defibrillator, pacemakers, neurostimulators, orthopedic stabilization, orthodontic appliances, dental implants.
dr n. med. Małgorzata Mojsak
Specjalista Medycyny Nuklearnej, Kierownik Samodzielnej Pracowni Obrazowania Molekularnego Uniwersytetu Medycznego w Białymstoku
dr n. med. Piotr Szumowski
Specjalista medycyny nuklearnej, Wykładowca UMB
dr n. med. Bożena Kubas
Specjalista Radiologii, Wykładowca UMB Konsultant Wojewódzki w dziedzinie Radiologii i Diagnostyki Obrazowej
dr Iwona Łachmacka
Specjalista Radiologii, Wykładowca UMB
dr n. med. Marcin Hładuński
Elektroradiolog, Wykładowca UMB
mgr Anna Amelian
dr n. med. Krystyna Klimaszewska
mgr Rafał Palkowski
mgr Ewa Szewczuk
Specjalista fizyki medycznej, Inspektor Ochrony Radiologicznej IOR-3
Cennik badań PET/MR (cena brutto w PLN)
|Rodzaj badania||Zastosowany radiofarmaceutyk||Cena badania||Cena badania w znieczuleniu|
|Skan całego ciała||18F-FDG||6,500.00||8,000.00|
|Skan całego ciała||18F-Fluorocholina||6,500.00||8,000.00|
|Skan całego ciała||68Ga-PSMA||8,500.00||10,000.00|
|Skan całego ciała||68Ga-DOTA-TATE||8,500.00||10,000.00|
|Skan całego ciała||68Ga-DOTA-TOC||8,500.00||10,000.00|
|Badanie głowy||18F-FET (tyrozyna)||18,500.00||20,000.00|
|Badanie głowy||18F Florbetaben (FBB)||11,000.00||12,000.00|
Cennik badań łączonych PET/CT i PET/MR (cena brutto w PLN)
|Rodzaj badania||Zastosowany radiofarmaceutyk||Cena badania||Cena badania w znieczuleniu|
|Skan całego ciała PET/CT + badanie piersi PET/MR||18F-FDG||5,500.00||7,000.00|
|Skan całego ciała||18F-FDG||7,600.00||9,150.00|
|Skan całego ciała||18F-Fluorocholina||8,100.00||9,650.00|
|Skan całego ciała||68Ga-PSMA||9,600.00||11,150.00|
|Skan całego ciała||68Ga-DOTA-TATE||9,600.00||11,150.00|
|Skan całego ciała||68Ga-DOTA-TOC||9,600.00||11,150.00|
|Skan całego ciała||18F-PSMA||16,500.00||18,050.00|
|Badanie głowy||18F-FET (tyrozyna)||20,000.00||21,550.00|
|Badanie głowy||18F-Florbetaben (FBB)||12,000.00||13,550.00|
What is the difference between PET/MR and PET/CTDetailed information on the differences between these examinations is presented on a dedicated subpage comparing examinations. The PET/MR examination is a multiparametric examination, which means two examinations in one, i.e. positron emission tomography examination and fully diagnostic 3-Tesla magnetic resonance imaging. By overlaying the images, the patient and their doctor receive more information that can help in making a diagnosis. In the case of PET/CT examinations, computed tomography is only auxiliary and is not fully diagnostic. In addition, the PET/MR examination is characterized by a much lower dose of ionizing radiation. For more information, please visit the subpage.
Could everyone perform PET MRI examination?Each time a decision about qualifying a patient is made by a medical doctor based on a medical history. According to our standards, patients receive a free qualification of a doctor specializing in nuclear medicine. It should be remembered that each PET MRI examination is associated with exposure to ionizing radiation (although the exposure is minimal, ionizing radiation should be used only in justified cases). In such cases, the ALARA principle is used – as low as reasonably achievable (as small doses of ionizing radiation as reasonably possible). Always diagnostic or therapeutic benefits obtained using an isotope must overcome the risk of exposure to ionizing radiation. Therefore, our specialists will evaluate and indicate the most beneficial diagnostic tests from the point of view of the patient's health.
Is exposure to ionizing radiation in the PET MRI test is high?No, because the doses of radiopharmaceuticals are selected individually for each patient (calculated on the basis of body weight – 4 MBq / 1 kg of body mass). We give the lowest possible doses of radiotracers, but sufficient to achieve the expected diagnostic benefits. When exposed to ionizing radiation and the selection of isotope doses, the ALARA principle is used – as low as reasonably achievable (as small doses as reasonably possible). In the case of PET / MRI studies, there is no additional exposure from magnetic resonance to ionizing radiation (in contrast to hybrid tests using PET / CT computed tomography). In addition, the unbound isotope is quickly excreted from the body mainly in the urine. The 18F isotope used for the study has a relatively short physical half-life – 110 minutes, i.e. after that time, half of the given radiotracer activity in the body becomes 220 min. there is already ¼ of the initial amount and so up to the complete decomposition of the radiotracer. According to the principles of radiation protection, it is assumed that after 10 half-lives (T1/2), the marker disintegrates completely.
Can I drive after the test?Yes, after the examination without general anesthesia, you can perform all daily activities, this also includes driving a car. Just remember to drink water (about 5 glasses) to help flush out the radioactive substance.
Do I have to stay in the hospital overnight for an examination under general anesthesia?There is no need. A PET/MR examination under general anesthesia is performed in the presence of an anaesthesiology specialist, however, it is still an outpatient examination, which means that the patient goes home on the same day.
Can the examination cause claustrophobia?This is possible because being in a confined space can cause anxiety or discomfort. To prevent this, you can ask your doctor to give you a sedative or perform an examination under general anesthesia.
How long will I be a source of radiation?Very low levels of radiation last for about 6-12 hours, up to a maximum of 24 hours.